Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in
   patients with previously untreated advanced or metastatic adenocarcinoma
   of the stomach or gastroesophageal junction: Moonlight, a randomized
   phase II trial of the German Gastric Group of the AIO

Dokumenttyp:: Meeting Abstract
Autor(en):: Lorenzen, S.; Pauligk, C.; Goetze, T. O.; Knorrenschild, J. Riera; Goekkurt, E.; Kullmann, F.; Pink, D.; Ettrich, T. J.; Homann, N.; Angermeier, S.; Thuss-Patience, P. C.; Lindig, U.; Bitzer, M.; Dechow, T.; Schuch, G.; Schmalenberg, H.; Junge, S.; Hofheinz, R. D.; Al-Batran, S-E.
Titel:: Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase II trial of the German Gastric Group of the AIO
Zeitschriftentitel:: Ann Oncol
Jahr:: 2019
Band / Volume:: 30
Print-ISSN:: 0923-7534
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: